Representation of women and racial minorities in SGLT2 inhibitors and heart failure clinical trials
Background: Inadequate representation of women and racial minorities in heart failure (HF) clinical trials continues to limit the generalizability of the results. This could create a disparity in treatment for future heart failure therapies and devices. The study aims to assess the representation of...
Saved in:
| Main Authors: | Rahul Gupta, Chukwuemeka Umeh, Tamanna Mohta, Ajay Vaidya, Aaron Wolfson, Jonathan Nattiv, Harpreet Bhatia, Gagan Kaur, Raghav Dhawan, Puja Darji, Benson Eghreriniovo, Eseosa Sanwo, Priya Hotwani, Payaam Mahdavian, Sabina Kumar, Bhoodev Tiwari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | International Journal of Cardiology: Heart & Vasculature |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352906724002057 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimización SGLT2 para cardionefro protección
by: Yukiko Harumi Yamasaki Ramos, et al.
Published: (2025-01-01) -
Research Progress of SGLT2 Inhibitors in Cancer Treatment
by: Miao X, et al.
Published: (2025-01-01) -
A study on the pharmacovigilance of various SGLT-2 inhibitors
by: Yanwen Dong, et al.
Published: (2025-01-01) -
The Role of SGLT2 Inhibitor on the Treatment of Diabetic Retinopathy
by: Wenjun Sha, et al.
Published: (2020-01-01) -
Hypertension approaches and recent SGLT2i studies
by: Zachary Bloomgarden
Published: (2024-11-01)